RecruitingNot ApplicableNCT06272461

Comparison of Intravenous Lidocaine vs Ketamine in Colorectal Surgery

The Effect of Intravenous Lidocaine or Ketamine on Interleukin-6 Levels in Patients Undergoing Colorectal Surgery for Cancer: A Randomized Controlled Trial


Sponsor

University Tunis El Manar

Enrollment

50 participants

Start Date

Oct 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

Patients undergoing open colorectal surgery were randomly divided into two groups: Intravenous Lidocaine (IV-Lido) vs Intravenous Ketamine (IV-Keta). For the IV-Lido group, patients received a loading dose of Lidocaine than a continuous infusion over twenty-four hours. For the IV-Keta goup, patients received a loading dose of Ketamine than a continuous injection of Ketamine over twenty-four hours. Plasma concentrations of Interleukin-6(IL-6) were measured preoperatively before anesthetic induction and at twenty-four hour post operatively.


Eligibility

Min Age: 18 YearsMax Age: 90 Years

Inclusion Criteria11

  • Patients aged 18 or older.
  • American society of anesthesiologists' (ASA) physical status of I-III.
  • Elective open colorectal surgery.
  • Patients with contraindications to lidocaine or ketamine.
  • Corticosteroid therapy within the last 6 months.
  • History of immunosuppressive therapy.
  • History of surgery in the last 3 months.
  • Personal medical history of inflammatory bowel disease.
  • Personal medical history of cardiac arrythmias or conduction disorders.
  • Alcohol or drug abuse.
  • Chronic use of opioids or benzodiazepines.

Exclusion Criteria2

  • Severe intraoperative complications.
  • Duration of surgery longer than 5 hours.

Interventions

DRUGLidocaine IV

Intravenous Lidocaine Vs intravenous Ketamine in colorectal surgery for cancer

DRUGKetamine Injectable Solution

Intravenous Lidocaine Vs intravenous Ketamine in colorectal surgery for cancer


Locations(1)

Tunisia

Nabeul, Tunisia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06272461


Related Trials